<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7182166\results\search\testTrace\results.xml">
  <result pre="nor a vaccine available against the virus, supportive management and" exact="treatment" post="with non-specific therapeutic agents (repurposed drugs) may provideÂ relief"/>
  <result pre="medical case handling, using personal protective equipment, proper and early" exact="diagnosis" post="of the disease, avoiding contact with the sick patients,"/>
  <result pre="of the disease, avoiding contact with the sick patients, and" exact="quarantine" post="of the infected/exposed people. coronavirus beta coronavirus respiratory and"/>
  <result pre="severe acute respiratory syndrome coronavirus-2 bats humans and animals aerosols" exact="quarantine" post="public health sars-cov-2 The content published in Cureus is"/>
  <result pre="the World Health Organization (WHO), and preliminary research results,Â the" exact="infection" post="with SARS-CoV-2, which was initially called as novel coronavirus"/>
  <result pre="novel coronavirus disease 2019 (nCOVID-19), could result in a human" exact="infection" post="that presents with signs and symptoms that include fever,"/>
  <result pre="people who presented with signs and symptoms of respiratory tract" exact="infection" post="in 1962Â [4]. The first cases of SARS were"/>
  <result pre="of ChinaÂ [11-13]. The newly discovered virus, causing a similar" exact="infection" post="(SARS-CoV), was initially named as nCoV 2019 (January 2020)"/>
  <result pre="[27-28]. Reintroduction into human beings from an animal reservoir, persistent" exact="infection" post="in previously sick people, or the laboratory strains may"/>
  <result pre="distress syndrome, evolving over one to two weeks. The preliminary" exact="infection" post="could be followed by a hyperactive immune reaction, which"/>
  <result pre="increase from two to seven days after the onset of" exact="infection" post="and usually include a non-productive cough and dyspnea. More"/>
  <result pre="infected patients (70-90%) were noted to develop lymphopeniaÂ [6]. Laboratory" exact="diagnosis" post="Laboratory tests, which are currently available for the diagnosis"/>
  <result pre="Laboratory diagnosis Laboratory tests, which are currently available for the" exact="diagnosis" post="ofÂ SARS-CoV-2 in various human clinical specimens (Sputum, throat"/>
  <result pre="specimens (Sputum, throat swab, nasal secretions, feces, blood/serum/plasma), include real-time" exact="polymerase chain reaction" post="(RT-PCR), viral cultural techniques for the isolation of virus"/>
  <result pre="real-time polymerase chain reaction (RT-PCR), viral cultural techniques for the" exact="isolation" post="of virus from clinical specimens, immunological tests for the"/>
  <result pre="isolation of virus from clinical specimens, immunological tests for the" exact="detection" post="of antibodies and antigens such as enzyme-linked immunosorbent assay,"/>
  <result pre="immunosorbent assay, indirect fluorescent antibody technique, rapid immunochromatographic tests, and" exact="immunofluorescence" post="techniquesÂ [7]. Other tests that may assist in the"/>
  <result pre="immunofluorescence techniquesÂ [7]. Other tests that may assist in the" exact="diagnosis" post="may include the flow-cytometry analysis for CD4+ and CD8+"/>
  <result pre="and the unavailability of specific anti-viral agents and a vaccine," exact="isolation" post="and quarantine of exposed/infected persons appear to be of"/>
  <result pre="unavailability of specific anti-viral agents and a vaccine, isolation and" exact="quarantine" post="of exposed/infected persons appear to be of increased significance"/>
  <result pre="threat to public health. Previous research had suggested that CoV" exact="infection" post="in pregnant women may result in poor obstetric consequences,"/>
  <result pre="of life of animals from the sickness and cost of" exact="treatment" post="for both animals and humans during the outbreakÂ [14]."/>
  <result pre="no single specific anti-viral therapy available against COVID, and the" exact="treatment" post="is mostly supportive. The cases of 2019 nCoV (SARS-CoV-2)"/>
  <result pre="treatment is mostly supportive. The cases of 2019 nCoV (SARS-CoV-2)" exact="infection" post="have been continuously increasing throughout the world ever since"/>
  <result pre="inhibit the catalytic area and inactivate the virusÂ [11,14]. Anti-viral" exact="treatment" post="with interferon-alpha inhalation (50 Î¼g two times daily), lopinavir"/>
  <result pre="(200 mg two times every day) is recommended. Patients obtained" exact="treatment" post="with a corticosteroid (40-80 mg/day) and gamma globulin (15-20"/>
  <result pre="and longer intensive care unit (ICU) stay. Strict adherence to" exact="infection" post="control guidelines is mandatory while performing tracheostomy in the"/>
  <result pre="of the tracheostomy tube. Care should be taken during the" exact="treatment" post="procedures to reduce complications and the chances of transmissionÂ"/>
  <result pre="nosocomial transmission, and, therefore, it is important to enhance ordinary" exact="infection" post="control measures in healthcare settings. Healthcare facilities must additionally"/>
  <result pre="the primary prevention strategies that deal with stopping transmission of" exact="infection" post="to increase personal protection for individuals; secondary prevention focused"/>
  <result pre="protection for individuals; secondary prevention focused on detecting the SARS" exact="infection" post="as early as possible and referring suspected individuals to"/>
  <result pre="as early as possible and referring suspected individuals to the" exact="quarantine" post="or emergency room in the nearby medical center if"/>
  <result pre="Early recognition of the disease, rapid diagnosis, isolation, and stringent" exact="infection" post="control measures are the keys to control this highly"/>
  <result pre="and contact precautions (hand hygiene, gown, gloves, masks, eye protection)," exact="contact tracing," post="and quarantine/isolation of close contacts are all important measures"/>
  <result pre="are all important measures in controlling the spread of the" exact="infection" post="in the hospital and the communityÂ [42]. Effective staff"/>
  <result pre="the hospital and the communityÂ [42]. Effective staff education in" exact="infection" post="control, personal protection equipment (PPE), disinfecting the environment, controlling"/>
  <result pre="each country of the world should give attention to the" exact="diagnosis" post="and prevention of the disease and have quarantine facilities"/>
  <result pre="to the diagnosis and prevention of the disease and have" exact="quarantine" post="facilities where the suspected persons can be kept in"/>
  <result pre="quarantine facilities where the suspected persons can be kept in" exact="isolation" post="until the confirmation of the disease or otherwise, and"/>
  <result pre="all healthcare centers should have personal protective equipment during the" exact="diagnosis" post="and identification of the disease. The governments of the"/>
  <result pre="and control and to discover a specific drug for the" exact="treatment" post="of the disease. Most importantly, timely disease surveillance and"/>
  <result pre="originating in ChinaCell Host MicrobeWuAPengYHuangBet al.32532827202032035028 29The aetiology, origins, and" exact="diagnosis" post="of severe acute respiratory syndromeLancet Infect DisPoonLLGuanYNichollsJMYuenKYPeirisJS6636714200415522678 30Management of"/>
  <result pre="III interferon receptor independent mechanismPLoS PathogFriemanMBChenJMorrisonTEet al.062010 41Advances in clinical" exact="diagnosis" post="and treatment of severe acute respiratory syndromeWorld J GastroenterolNieQHLuoXDHuiWL113911439200312800213"/>
  <result pre="receptor independent mechanismPLoS PathogFriemanMBChenJMorrisonTEet al.062010 41Advances in clinical diagnosis and" exact="treatment" post="of severe acute respiratory syndromeWorld J GastroenterolNieQHLuoXDHuiWL113911439200312800213 42The economic"/>
  <result pre="an enzyme-linked immunosorbent assay and an immunochromatographic test for serological" exact="diagnosis" post="of severe acute respiratory syndromeClin Diagn Lab ImmunolGuanMChanKHPeirisJS69970311200415242944 44Laboratory"/>
  <result pre="diagnosis of severe acute respiratory syndromeClin Diagn Lab ImmunolGuanMChanKHPeirisJS69970311200415242944 44Laboratory" exact="diagnosis" post="of SARSEmerg Infect DisChanPKToWKNgKCet al.82583110200415200815 45Severe acute respiratory syndrome"/>
  <result pre="coronavirusN Engl J MedPerlmanS760762382202031978944 49Severe acute respiratory syndrome: report of" exact="treatment" post="and outcome after a major outbreakThoraxSungJJWuAJoyntGMet al.41442059200415115870 50Lessons from"/>
 </snippets>
</snippetsTree>
